TG and metastatic neoplasm: Not only is a high stimulated Tg level of >10 μg/mL considered an indicator of recurrent/metastatic disease in patients with DTC, but a high stimulated Tg level of ≥50 μg/mL is associated with shorter PFS and OS in patients with DTC (32).